DFJ
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Evidence names DFJ as lead investor in an AI-based drug discoverer financing round, indicating appetite for AI-enabled biotech platforms relevant to OpenDrugs' evidence-first longevity and drug discovery positioning.